RNA Splicing

• Understand what is RNA splicing and why it's essential for eukaryotic gene expression
• Identify the key molecular players including the spliceosome, snRNAs, and splicing factors
• Analyze the two-step transesterification mechanism that removes introns and joins exons
• Compare constitutive splicing with alternative splicing patterns in human genes
• Recognize splice site sequences and regulatory elements that control splicing accuracy
• Evaluate how splicing errors contribute to genetic diseases and cancer development
• Apply knowledge of splicing mechanics to predict outcomes of splice site mutations
• Explore the evolutionary significance of splicing in increasing protein diversity

What is RNA Splicing: The Molecular Editor of Gene Expression

What is RNA splicing? It's one of the most remarkable molecular processes in eukaryotic cells, where newly transcribed pre-mRNA undergoes precise editing to remove non-coding sequences called introns. This process transforms immature RNA into mature messenger RNA (mRNA) ready for protein synthesis. Unlike prokaryotes, where genes are continuous coding sequences, eukaryotic genes contain interrupting sequences that must be removed through this sophisticated splicing machinery.

The Spliceosome: Nature's Precision Editing Complex

The spliceosome represents one of the largest and most dynamic ribonucleoprotein complexes in eukaryotic cells. This massive molecular machine, comparable in size to a ribosome, assembles de novo on each pre-mRNA substrate. The spliceosome contains five small nuclear RNAs (U1, U2, U4, U5, and U6 snRNAs) along with over 150 associated proteins. These components work together to recognize specific sequences at intron boundaries: the 5' splice site (typically GT), the 3' splice site (typically AG), and the branch point sequence containing an adenosine residue located 20-50 nucleotides upstream of the 3' splice site.

Mechanism and Biological Significance

The splicing reaction proceeds through two sequential transesterification reactions. First, the branch point adenosine attacks the 5' splice site, creating a lariat intermediate. Second, the free 3'-hydroxyl group of the upstream exon attacks the 3' splice site, joining the exons and releasing the intron lariat. This mechanism ensures high fidelity while allowing for regulatory control through splicing enhancers and silencers recognized by SR proteins and other splicing factors.

Alternative Splicing and Medical Relevance

Alternative splicing dramatically expands the human proteome, allowing approximately 20,000 genes to produce over 100,000 different proteins. This process is particularly relevant for students preparing for the MCAT or AP Biology exams, as it explains how genetic complexity arises despite having fewer genes than simpler organisms. Clinically, splicing defects cause numerous human diseases, including spinal muscular atrophy (affecting SMN1 gene splicing), various cancers (involving tumor suppressor gene splicing), and Hutchinson-Gilford progeria syndrome (resulting from aberrant LMNA splicing). Understanding these mechanisms is crucial for students pursuing careers in genetic counseling, molecular medicine, or biotechnology research at institutions like the National Institutes of Health or pharmaceutical companies developing splice-modulating therapeutics.